HealthEquity
Market Cap
US$4.4b
Last Updated
2020/10/26 05:25 UTC
Data Sources
Company Financials +
Executive Summary
HealthEquity, Inc. providing technology-enabled services platforms to consumers and employers in the United States. More Details
Rewards
Risk Analysis
Snowflake Analysis
Moderate growth potential and slightly overvalued.
Similar Companies
Share Price & News
How has HealthEquity's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: HQY has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
10.8%
HQY
1.7%
US Healthcare
0.4%
US Market
1 Year Return
-2.9%
HQY
22.7%
US Healthcare
17.8%
US Market
Return vs Industry: HQY underperformed the US Healthcare industry which returned 22.7% over the past year.
Return vs Market: HQY underperformed the US Market which returned 17.8% over the past year.
Shareholder returns
| HQY | Industry | Market | |
|---|---|---|---|
| 7 Day | 10.8% | 1.7% | 0.4% |
| 30 Day | 21.2% | 10.8% | 6.1% |
| 90 Day | 9.3% | 7.6% | 8.9% |
| 1 Year | -2.9%-2.9% | 24.3%22.7% | 20.5%17.8% |
| 3 Year | 17.6%17.6% | 37.2%31.4% | 42.3%32.9% |
| 5 Year | 74.8%74.8% | 66.3%54.1% | 84.2%63.4% |
Price Volatility Vs. Market
How volatile is HealthEquity's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall St
Does HealthEquity's (NASDAQ:HQY) CEO Salary Compare Well With The Performance Of The Company?1 month ago | Simply Wall St
Is It Time To Consider Buying HealthEquity, Inc. (NASDAQ:HQY)?1 month ago | Simply Wall St
Calculating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)Valuation
Is HealthEquity undervalued compared to its fair value and its price relative to the market?
22.9%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: HQY ($57.66) is trading below our estimate of fair value ($74.81)
Significantly Below Fair Value: HQY is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: HQY is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.
PE vs Market: HQY is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate HQY's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: HQY is overvalued based on its PB Ratio (3.3x) compared to the US Healthcare industry average (3.2x).
Next Steps
Future Growth
How is HealthEquity forecast to perform in the next 1 to 3 years based on estimates from 14 analysts?
112.8%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HQY is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).
Earnings vs Market: HQY is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: HQY's is expected to become profitable in the next 3 years.
Revenue vs Market: HQY's revenue (9.1% per year) is forecast to grow slower than the US market (9.9% per year).
High Growth Revenue: HQY's revenue (9.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if HQY's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has HealthEquity performed over the past 5 years?
12.9%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: HQY is currently unprofitable.
Growing Profit Margin: HQY is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: HQY is unprofitable, but has reduced losses over the past 5 years at a rate of 12.9% per year.
Accelerating Growth: Unable to compare HQY's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HQY is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (31.2%).
Return on Equity
High ROE: HQY has a negative Return on Equity (-1.48%), as it is currently unprofitable.
Next Steps
Financial Health
How is HealthEquity's financial position?
Financial Position Analysis
Short Term Liabilities: HQY's short term assets ($383.1M) exceed its short term liabilities ($153.8M).
Long Term Liabilities: HQY's short term assets ($383.1M) do not cover its long term liabilities ($1.2B).
Debt to Equity History and Analysis
Debt Level: HQY's debt to equity ratio (75.2%) is considered high.
Reducing Debt: Insufficient data to determine if HQY's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: HQY's debt is not well covered by operating cash flow (11.6%).
Interest Coverage: HQY is unprofitable, therefore interest payments are not well covered by earnings.
Balance Sheet
Next Steps
Dividend
What is HealthEquity current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate HQY's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate HQY's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if HQY's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if HQY's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of HQY's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
3.4yrs
Average management tenure
CEO
Jon Kessler (52 yo)
6.67yrs
Tenure
US$5,265,794
Compensation
Mr. Jon Kessler is a Member of the Board of Managers at HealthEquity Advisors, LLC. He has been the Chief Executive Officer and President at HealthEquity, Inc. since February 2014. Mr. Kessler founded Wage ...
CEO Compensation Analysis
Compensation vs Market: Jon's total compensation ($USD5.27M) is about average for companies of similar size in the US market ($USD5.60M).
Compensation vs Earnings: Jon's compensation has increased whilst the company is unprofitable.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.67yrs | US$5.27m | 0.48% $ 21.2m | |
| Executive VP & CFO | 13.67yrs | US$2.07m | 0.052% $ 2.3m | |
| Executive VP & COO | 2.17yrs | US$2.61m | 0.0049% $ 216.3k | |
| Executive VP | 0.33yr | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| Executive VP | 4.08yrs | US$1.53m | 0.0043% $ 188.8k | |
| Senior VP of Compliance & Regulatory Affairs | 1.08yrs | no data | no data | |
| Senior Vice President of Corporate Development | 3.5yrs | no data | no data | |
| Executive Vice President of Sales | 3.42yrs | US$2.09m | 0.020% $ 900.1k | |
| Executive VP & Chief Marketing Officer | 1.5yrs | no data | 0.0036% $ 158.7k | |
| Senior Vice President of People | no data | no data | no data | |
| Senior Vice President of Relationship Management | no data | no data | no data |
3.4yrs
Average Tenure
48yo
Average Age
Experienced Management: HQY's management team is considered experienced (3.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.67yrs | US$5.27m | 0.48% $ 21.2m | |
| Independent Director | 4.08yrs | US$242.50k | 0.034% $ 1.5m | |
| Independent Non-Executive Chairman | 5.08yrs | US$310.00k | 0.043% $ 1.9m | |
| Independent Director | 6.17yrs | US$245.00k | 0.015% $ 666.1k | |
| Independent Director | 6.25yrs | US$227.50k | 0.0060% $ 263.7k | |
| Founder & Vice Chairman | 6.67yrs | US$2.06m | 1.05% $ 46.7m | |
| Independent Director | 16.5yrs | US$237.50k | 0.19% $ 8.6m | |
| Independent Director | 3.17yrs | US$227.50k | 0.0092% $ 408.6k | |
| Independent Director | 2.5yrs | US$212.50k | 0.0087% $ 386.0k |
6.2yrs
Average Tenure
59yo
Average Age
Experienced Board: HQY's board of directors are considered experienced (6.2 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.8%.
Top Shareholders
Company Information
HealthEquity, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: HealthEquity, Inc.
- Ticker: HQY
- Exchange: NasdaqGS
- Founded: 2002
- Industry: Managed Health Care
- Sector: Healthcare
- Market Cap: US$4.432b
- Shares outstanding: 76.86m
- Website: https://www.healthequity.com
Number of Employees
Location
- HealthEquity, Inc.
- 15 West Scenic Pointe Drive
- Suite 100
- Draper
- Utah
- 84020
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| HQY | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Jul 2014 |
| 2HE | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Jul 2014 |
Biography
HealthEquity, Inc. providing technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spendi ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/10/26 05:25 |
| End of Day Share Price | 2020/10/23 00:00 |
| Earnings | 2020/07/31 |
| Annual Earnings | 2020/01/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.